A detailed history of Jpmorgan Chase & CO transactions in Petmed Express Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 23,481 shares of PETS stock, worth $107,542. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,481
Previous 87,952 73.3%
Holding current value
$107,542
Previous $356,000 75.84%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$2.94 - $4.04 $189,544 - $260,462
-64,471 Reduced 73.3%
23,481 $86,000
Q2 2024

Aug 12, 2024

SELL
$3.95 - $4.84 $145,885 - $178,755
-36,933 Reduced 29.57%
87,952 $356,000
Q1 2024

May 10, 2024

SELL
$4.7 - $7.58 $21,967 - $35,428
-4,674 Reduced 3.61%
124,885 $598,000
Q4 2023

Feb 12, 2024

BUY
$6.89 - $11.04 $399,640 - $640,353
58,003 Added 81.06%
129,559 $979,000
Q3 2023

Nov 14, 2023

BUY
$10.21 - $14.65 $64,200 - $92,119
6,288 Added 9.63%
71,556 $733,000
Q2 2023

Aug 11, 2023

BUY
$13.68 - $16.56 $117,347 - $142,051
8,578 Added 15.13%
65,268 $900,000
Q1 2023

May 18, 2023

BUY
$15.9 - $22.22 $245,845 - $343,565
15,462 Added 37.5%
56,690 $920,000
Q1 2023

May 11, 2023

SELL
$15.9 - $22.22 $1,272 - $1,777
-80 Reduced 0.19%
41,228 $669,000
Q4 2022

Feb 13, 2023

BUY
$17.16 - $22.14 $64,023 - $82,604
3,731 Added 9.93%
41,308 $731,000
Q3 2022

Nov 14, 2022

BUY
$19.35 - $23.52 $132,953 - $161,605
6,871 Added 22.38%
37,577 $733,000
Q2 2022

Aug 11, 2022

BUY
$19.9 - $26.13 $98,763 - $129,683
4,963 Added 19.28%
30,706 $611,000
Q1 2022

May 11, 2022

SELL
$23.62 - $29.18 $427,403 - $528,012
-18,095 Reduced 41.28%
25,743 $664,000
Q4 2021

Feb 10, 2022

SELL
$25.26 - $32.0 $431,668 - $546,848
-17,089 Reduced 28.05%
43,838 $1.11 Million
Q3 2021

Nov 12, 2021

BUY
$26.5 - $34.0 $1.61 Million - $2.07 Million
60,927 New
60,927 $1.64 Million

Others Institutions Holding PETS

About PETMED EXPRESS INC


  • Ticker PETS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Pharmaceutical Retailers
  • Shares Outstandng 21,013,800
  • Market Cap $96.2M
  • Description
  • PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint c...
More about PETS
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.